Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1948 1
1949 2
1950 1
1952 3
1953 1
1956 1
1957 1
1959 3
1960 2
1963 2
1964 4
1965 3
1967 1
1968 3
1969 3
1970 1
1971 4
1972 1
1973 4
1974 3
1975 7
1976 6
1977 5
1978 3
1979 2
1980 3
1981 4
1982 6
1983 2
1984 2
1985 6
1986 6
1987 3
1988 5
1989 2
1990 4
1991 3
1992 2
1993 6
1994 7
1995 3
1996 2
1997 3
1998 4
2000 3
2001 3
2002 3
2003 6
2004 2
2005 9
2006 3
2007 3
2008 6
2009 4
2010 5
2011 5
2012 7
2013 7
2014 5
2015 7
2016 9
2017 5
2018 6
2019 11
2020 3
2021 2
2022 4
2023 4
2024 6
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group. Feagan BG, et al. N Engl J Med. 2016 Nov 17;375(20):1946-1960. doi: 10.1056/NEJMoa1602773. N Engl J Med. 2016. PMID: 27959607 Free article. Clinical Trial.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
Scheduling.
Schulman ML. Schulman ML. J Clin Orthod. 1984 Jun;18(6):427-9. J Clin Orthod. 1984. PMID: 6590561 No abstract available.
Scheduling.
Schulman ML. Schulman ML. J Clin Orthod. 1977 Mar;11(3):199-202. J Clin Orthod. 1977. PMID: 273612 No abstract available.
Efficacy of a Pseudomonas aeruginosa serogroup O9 vaccine.
Moustafa DA, DiGiandomenico A, Raghuram V, Schulman M, Scarff JM, Davis MR Jr, Varga JJ, Dean CR, Goldberg JB. Moustafa DA, et al. Among authors: schulman m. Infect Immun. 2023 Dec 12;91(12):e0024723. doi: 10.1128/iai.00247-23. Epub 2023 Nov 22. Infect Immun. 2023. PMID: 37991349 Free PMC article.
New therapeutic approaches.
Hanauer SB, Schulman MI. Hanauer SB, et al. Among authors: schulman mi. Gastroenterol Clin North Am. 1995 Sep;24(3):523-40. Gastroenterol Clin North Am. 1995. PMID: 8809234 Review.
253 results